Sen. Tammy Baldwin

Maddy summaryThe PARTNERS Act of 2023 creates a federal grant program to help small and medium-sized businesses develop registered apprenticeship programs in high-demand industries. It provides states with funding to award grants (up to $500,000 per partnership for 3 years) to industry partnerships that support apprenticeships through business engagement services and worker support. Grants require partnerships to provide at least 12 months of wrap-around services (like childcare, transportation, and mentorship) for workers, including individuals with barriers to employment. The program tracks outcomes by demographics to ensure accessibility for historically underrepresented groups in participating industries.

Maddy summaryThis bill amends rules for orphan drug exclusivity under U.S. drug law. It changes the definition of "rare disease or condition" to specifically refer to the "approved use or indication" for which a drug was initially approved. This means exclusivity periods now apply to specific medical uses (e.g., treating a particular symptom of a rare disease), not just the broad disease name. The change affects drug manufacturers developing new treatments for rare diseases and the FDA in evaluating exclusivity claims, applying to all drugs designated under current law regardless of when they were approved.

Maddy summaryThe Ensuring Timely Access to Generics Act of 2023 requires drug manufacturers to submit a petition to the FDA within 60 days of knowing the information that would form the basis of a challenge before filing a lawsuit to delay generic drug approvals. The FDA must evaluate factors like multiple petitions, lack of supporting data, or timing close to approval deadlines to determine if a petition was filed primarily to delay approval. If a lawsuit is filed without following this petition process, courts must dismiss it (without prejudice for missing the petition, with prejudice for late filing). The bill also mandates that the FDA refer petitions deemed to delay approvals to the Federal Trade Commission for review. This aims to streamline the approval process for generic drugs by reducing strategic delays.

Maddy summarySRES 263 is a symbolic Senate resolution commemorating June 19, 2023, as "Juneteenth National Independence Day" to recognize June 19, 1865 - the date Union troops announced the end of slavery in Texas. It honors the historical significance of this date, when news of emancipation reached enslaved people in the Southwestern U.S. after the Civil War. The resolution does not create new laws or policies but formally acknowledges this observance as part of U.S. history and heritage, supporting nationwide recognition of the event. It affects all Americans by affirming a shared historical moment in the nation's journey toward freedom.

This resolution designates June 2023 as National Post-Traumatic Stress Awareness Month and June 27, 2023, as National Post-Traumatic Stress Awareness Day. The resolution supports (1) the education of members of the Armed Forces, veterans, their families, and the public about post-traumatic stress; and (2) efforts by the Department of Veterans Affairs and the Department of Defense to foster cultural change around the issue of post-traumatic stress. The resolution also encourages the leadership of the Armed Forces to support treatment of members of the Armed Forces who suffer from post-traumatic stress.

Maddy summaryThis bill amends federal rail service law to require rail carriers to meet shippers' reasonable service needs. It specifies factors carriers must consider - like crew availability, equipment maintenance, and delivery timelines - when fulfilling service requests. Disputes over service violations must be resolved within 180 days, and regulators can set enforceable service standards like delivery times if carriers fail to comply. The law directly affects rail carriers and their business customers using rail transport for shipping goods.

Maddy summaryThe Equality Act (S 5) amends federal civil rights laws to explicitly prohibit discrimination based on sexual orientation and gender identity in public accommodations, employment, housing, credit, and jury service. It expands existing protections under the Civil Rights Act of 1964 by clarifying that discrimination based on sexual orientation or gender identity constitutes sex discrimination, as established by the Supreme Court's Bostock decision. The bill directly affects businesses, employers, housing providers, financial institutions, and government services that receive federal funding, requiring them to provide equal access and treatment regardless of sexual orientation or gender identity. It includes specific provisions addressing discrimination in foster care and adoption, where LGBTQ individuals often face barriers, and clarifies definitions of terms like "gender identity" and "sexual orientation" for consistent application. The law creates a uniform national standard for nondiscrimination where many states lack such protections, aiming to eliminate barriers to full participation in society for LGBTQ individuals.

Maddy summaryThis bill amends the Public Health Service Act to prioritize pandemic preparedness for unknown viral threats. It directs the Secretary to develop platform manufacturing technologies for rapid medical countermeasures and fund flexible research against high-risk respiratory viruses (including pathogen-agnostic approaches). The bill authorizes $40 million annually (2024-2028) for these specific purposes, requiring that products developed with this funding be substantially manufactured in the U.S. unless waived for public interest reasons. It directly affects federal health agencies managing pandemic response and U.S. manufacturers receiving these funds.

Maddy summaryThis bill adds multi-cancer early detection screening tests to Medicare Part B coverage, directly affecting Medicare beneficiaries. It creates a new coverage category for FDA-approved blood tests (like those analyzing cell-free DNA) that screen for multiple cancer types simultaneously, as defined in the bill. Medicare would cover these tests once every 12 months, and the bill clarifies that this change does not impact existing coverage for standard cancer screenings like mammograms or colonoscopies. The policy change ensures beneficiaries can access these new screening options without unnecessary delays after FDA approval.

Maddy summaryS 886 (Women's Suffrage National Monument Location Act) specifies the location for the Women's Suffrage National Monument. It directs the monument to be placed within the "Reserve" area, overriding a previous location provision under 40 U.S.C. § 8908(c). This procedural bill does not change monument policies or affect people; it only sets the physical site for a monument already authorized by Public Law 116-217. The Commemorative Works Act generally applies, except for the specified location.